Upper gastrointestinal bleeding: Etiology and management
Symposium on Hepatology-II
10.1007/BF02859378 Cite this article as: Arora, N.K., Ganguly, S., Mathur, P. et al. Indian J Pediatr (2002) 69: 155. doi:10.1007/BF02859378 Abstract
Upper gastrointestinal bleeding is a potentially fatal condition at times due to loss of large volumes of blood. Common sources of upper gastrointestinal bleeding in children include mucosal lesions and variceal hemorrhage (most commonly extra hepatic portal venous obstruction) and, in intensive care settings infections and drugs are other etiological factors associated with bleeding. Massive upper Gl bleeding is life threatening and requires immediate resuscitation measures in the form of protection of the airways, oxygen administration, immediate volume replacement with ringer lactate or normal saline, transfusion of whole blood or packed cells and also monitoring the adequacy of volume replacement by central venous lines and urine output. Upper Gl endoscopy is an effective initial diagnostic modality to localize the site and cause of bleeding in almost 85–90% of patients. Antacids supplemented by H2-receptor antagonists, proton pump inhibitors and sucralfate are the mainstay in the treatment of bleeding from mucosal lesion. For variceal bleeds, emergency endoscopy is the treatment of choice after initial haemodynamic stabilization of patient. If facilities for endoscopic sclerotherapy (EST) are not available, pharmacotherapy which decreases the portal pressure is almost equally effective and should be resorted to. Shunt surgery is reserved for patients who do not respond to the above therapy. β blockers combined with sclerotherapy have been shown to be the most effective therapy in significantly reducing the risk of recurrent rebleeding from varices as well as the death rates, as compared to any other modality of treatment. Based on studies among adult patients, presence of shock, co-morbidities, underlying diagnosis, presence of stigmata of recent hemorrhage on endoscopy and rebleeding are independent risk factors for mortality due to upper Gl bleeding. Rebleeding is more likely to occur if the patient has hematemesis, liver disease, coagulopathy, hypotension and or anemia. There is a great need for conducting therapeutic trials as well as identifying predictors of outcome of upper Gl bleeding in children to develop evidence based management protocols.
Key words Acute upper Gl bleed Etiology Management Portal hypertension References
Yachha SK, Khanduri A, Sharma BC, Kumar M. Gastrointestinal bleeding in children.
J Gastroenterol Hepat 1996; 11: 903–907.
Oslon AD, Hillemeier AC. Gastrointestinal hemorrhage. In Walker WA, ed.
Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. St. Louis, Mosby 1996, 251–270.
Mittal SK, Kalra KK, Agarwal V. Diagnostic upper GI endoscopy for hemetemesis in children. Experience from a pediatric gastroenterology center in North India.
Indian J Pediatr
1994; 61: 651–654.
Cox K, Ament ME. Upper gastrointestinal bleeding in children and adolescents.
1979; 63 (3): 408–413.
Fleischer D. Etiology and prevalence of severe persistent upper gastrointestinal bleeding.
1983; 84: 538–543.
Gostout CJ, Kenneth KW, Ahlquist DA
Acute gastrointestinal bleeding. Experience of a specialized management team.
J Clin Gastroenterol
1992; 14(3): 260–267.
Lacorix J, Nadeau D, Lakerge S, Gauthier M, Lapierre G, Farrel CA. Frequency of upper gastrointestinal bleeding in a pediatric intensive care unit.
Crit Core Med
1992; 20: 35–42.
Gormally S. Gastritis and Peptic Ulcer Disease. In Walker WA ed.
Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. St. Louis, Mosby 1996; 506–527.
Drumm B, Rhoads JM, Stringer DA
Peptic ulcer disease in children: Etiology, clinical findings and clinical course.
1988; 82 : 410–414.
Drumm B, Perez-Perez GI, Blaser MJ, Sherman PM. Intra familial clustering in helicobacter pylori infection.
N Engl J Med
1990; 322 (6): 359–363.
et al. Helicobacter pylori and associated duodenal ulcer. Ardi Dis Child 1990; 65: 1212–1216.
Labenz J, Peitz U, Kohl H, Kaiser J, Malfertheiner P, Hackersberger
Helicobacter pylori increases the risk of peptic ulcer bleeding: a casecontrol study.
Ital J Gastroenterol Hepatol
1999; 31(2): 110–115.
Chan FK, Chung SC, Suen BY, Lee YT, Leung WK, Leung VK
Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking lowdose aspirin or naproxen.
N Engl J Med
2001; 344 (13): 967–973.
Katelaris PH, Tippet GH, Norbu P, Lowe DG, Brennan R, Farming MJ. Dyspepsia, helicobacter pylori and peptic ulcer in a randomly selected population in India.
1992; 33: 1462–1466.
Gill HH, Majumdar P, Shankaran K, Desai HG. Age related prevalence of helicobacter pylori antibodies in Indian subjects.
Indian J Gastroenter 1994; 13(3): 92–94.
Roduquez LAG, Herschel J. Risk of upper gastrointestinal bleeding and perforation associated with individual non steroidal anti inflammatory drugs.
1994; 343: 769–772.
et al. Effect of 16 — dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin treated canine gastric mucosa. Gastroenterology 1985; 88: 308–314.
Fromm D. How do non steroidal anti inflammatory drugs affect gastric mucosal defences ?
Clin Invest Med
1987; 10: 251–258.
Association of adreno corticosteroid therapy and peptic ulcer disease.
N Engl J Med
1983; 309: 21–24.
Prandi D, Rueff B, Roche-Sicot J
Life threatening hemorrhage of the digestive tract in cirrhotic patients.
Am J Surg
1976; 131: 204–209.
Arora NK, Lodha R, Arora N. Portal hypertension. In Suraj Gupte, ed.
Recent Advances in Pediatr 1998 : 317-348.
Alvarez F, Bernard O, Brunelle F
Portal hypertension in children: Clinical investigatons and hemorrhage risk.
1983; 103: 696–702.
Arora NK, Lodha R, Gulati S, Gupta AK, Mathur P, Joshi Medha S. Portal Hypertension in North Indian Children.
Indian J Pediatr
1998; 65: 585–591.
Rector WG, Reynolds TB. Risk factors for hemorrhage from esophageal varices and acute gastric erosions.
1985; 14: 139–153.
Sarin SK, Sundaram KR, Ahuja RK. Predictors of variceal bleeding.
1989; 30: 1757–1764.
Prolla J, Diehl AS, Benvenuti GA
Upper gastrointestinal fiberoptic endoscopy in pediatric patients.
1983; 29: 279–281.
Leincke J, Schaffer R, Hogan W. Emergency endoscopy in acute upper GI bleeding(UGB): does timing affect the significance of diagnostic yield?
Gastrointest Endosc 1976; 22: 32–38.
Boyan C. Cold or warm blooded for massive transfusion.
Am Surg 1964; 160–182.
Katon R. Complications of upper gastrointestinal endoscopy in the gastrointestinal bleeder.
Dig Dis Sd 1981; 26: 475–545.
Hoare AM. Comparative study between endoscopy and radiology in acute upper gastrointestinal hemorrhage.
Br Med J
1975; 1: 27.
Driscoll D. The role of radionudide imaging in the diagnosis of gastrointestinal bleeding in children.
1986; 52: 237–239.
Afshani E, Bergee P. Gastrointestinal tract angiography in infants & children.
J Pediatr Gastroenterol Nutr
1986; 5: 173–186.
Alavi A, Ringh E. Localisation of gastrointestinal bleeding: superiority of 99mTc sulfur colloid compared with angiography.
Am J Roent 1981; 137: 741–748.
Keller F, Rosch J. Value of angiography in diagnosis and therapy of acute upper gastrointestinal hemmorrhage.
Dig Dis Sd 1981; 26: 785–895.
Meyerontz M, Fellows K. Angiography in gastrointestinal bleed in children.
Am J Roentgenol 1984; 143: 837–840.
Levine RS, Steinberg WM. Antacids: in Gastrointestinal Pharamacotherapy. WB Saunders & Co. Philadelphia. 1st edn. 1993.
Zeldir JB, Friedman LS, Isselbacher KJ. Ranitidine: A new H2 receptor antagonist.
N Eng J Med
1983; 309: 1368.
Clissold SP, Campoli-Richard DM. Omeprazole-A prelimnary review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
1986; 32: 15–47.
Nasgashima R. Mechanism of action of sucralfate.
J Clin Gastroenterol 1981; 3 (suppl 2): 117.
D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: A meta analytic review.
1995; 22(1): 332–354.
Boles ET. Portal hypertension. In, Holder TM, Ashoraft WF, eds.
Pediatric Surgery WB Saunders, London, 1980; 534.
Westaby D, Melia WM, MacDougal BR
Injection sclerotherapy for esophageal varices. A prospective randomized controlled trial of different treatment schedules.
1984; 25: 129–132.
Baillie J, Yudelman P. Complications of endoscopic sclerotherapy of esophageal varices.
1992; 24: 284–291.
Hill ID, Bowie ND. Endoscopic sclerotherapy for control of bleeding varices in children.
Am J Gastroenterol
1991; 86 (4): 472–476.
Sasaki T, Hasegawa T, Nakajima K, Tanano H, Wasa M, Fukui Y
Endoscopic variceal ligation in the management of gastroesophageal varices in the post-operative biliary atresia.
J Ped Surg
1998; 33(11): 1628–1632.
Fleischer D. Endoscopic therapy of upper gastrointestinal bleeding in humans.
Gastroenterol 1986; 90: 217–234.
Papp JP. Endoscopic electro coagulation in the management of upper gastrointestinal bleeding.
Surg Clin of North Am 1982; 62: 797–806.
Sharara Al, Rockey DC. Gastresophageal variceal hemmorhage.
N Engl J Med
2001; 345(9): 669–681.
Haddock G, Garden OJ, MeKee RF
Esophageal tamponade in the management of acute variceal hemorrhage.
Dig Dis Sci
1989; 34: 913–918.
Evans S, Stovroff M, Heiss K, Ricketts R. Selective distal splenorenal shunts for intractable variceal bleeding in pediatric portal hypertension.
J Pediatr Surg
1995; 30(8): 1115–1118.
Shah R, Nagral SS, Mathur SK. Results of a modified Sugiura’s devascularisation in the management of ‘unshuntable’ portal hypertension.
1999; 11: 235–239.
Prasad AS, Subhash G, Vivek K, Pande GK, Shani P, Nundy S. Proximal splenorenal shunts for Extrahepatic portal Venous obstruction in children.
1994; 219(2): 193–196.
Goncalves ME, Cardosos SR, Maksoud JG. Prophylactic sclerotherapy in children with esophageal varices: Long term results of a controlled prospective randomized controlled trial.
J Pediatr Surg
2000; 35: 401–405.
Hayes PC, Davis JM, Lewis JA, Bouchier IAD. Meta — analysis of the value to propranolol in prevention of variceal hemorrhage.
1990; 336: 153–156.
Rockall TA, Logan RFA, Devlin HB, Northfield TC. Variation in outcome after acute upper gastrointestinal hemorrhage. The National Audit of Acute Upper Gastrointestinal Haemorrhage.
1995; 346: 346–349.
Rockall TA, Logan RFA, Devlin HB, Northfield TC. Risk assessment after upper gastrointestinal hemorrhage.
1996; 38: 316–321.
Terdimann JP, Ostroff JW. Risk of persistent or recurrent and intractable upper gastrointestinal bleeding in the era of therapeutic endoscopy.
Am J Gastroenterol 1997; 92(10): 1805–1811.
Corley DA, Stefan AM, Michael W, Cook EF, Lee TH. Early indicators of prognosis in upper gastrointestinal hemorrhage.
Am J Gastroenterol
1997; 93(3): 336–340.
CrossRef Copyright information
© Dr. K C Chaudhuri Foundation 2002